Back
Black Diamond Therapeutics Stock Price Chart
Sponsored
BDTX
Sponsored
Wall St Issues Rare "SELL" alert
MarketBeat is making the full list completely FREE for a limited time.
Sell
42
BDTX
Black Diamond Therapeutics
Last Price:
4.60
Seasonality Move:
-24.01%
7 Day Trial
ALL ACCESS PASS
$
7
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight buying pressure.
Black Diamond Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.97 | Sell |
20-day SMA: | 5.54 | Sell |
50-day SMA: | 5.63 | Sell |
200-day SMA: | 4.8 | Sell |
8-day EMA: | 4.92 | Sell |
20-day EMA: | 5.31 | Sell |
50-day EMA: | 5.46 | Sell |
200-day EMA: | 4.85 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 37.22 | Sell |
Chaikin Money Flow: | 116649 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.05 - 6.33) | Sell |
Bollinger Bands (100): | (4.76 - 6.2) | Sell |
Black Diamond Therapeutics Technical Analysis
Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 4.59 while BDTX 8-day simple moving average is 4.97, which is a Sell signal.
- The stock price of BDTX is 4.59 while Black Diamond Therapeutics 20-day SMA is 5.54, which makes it a Sell.
- Black Diamond Therapeutics 50-day simple moving average is 5.63 while BDTX share price is 4.59, making it a Sell technically.
- BDTX stock price is 4.59 and Black Diamond Therapeutics 200-day simple moving average is 4.80, creating a Sell signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
42
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $4.59. The Score for BDTX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
259.36M
Price in USD:
4.59
Share Volume:
2.53M
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
1.62
Sell
42
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 4.59 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 4.59 while BDTX 8-day exponential moving average is 4.92, which is a Sell signal.
- The stock price of BDTX is 4.59 while Black Diamond Therapeutics 20-day EMA is 5.31, which makes it a Sell.
- Black Diamond Therapeutics 50-day exponential moving average is 5.46 while BDTX share price is 4.59, making it a Sell technically.
- BDTX stock price is 4.59 and Black Diamond Therapeutics 200-day simple moving average is 4.85, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.59 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Black Diamond Therapeutics is a Sell
- Black Diamond Therapeutics Relative Strength Index (RSI) is 37.22, which suggest Black Diamond Therapeutics is oversold
- The Bollinger Bands (25) for Black Diamond Therapeutics is (5.05 - 6.33), which suggest Black Diamond Therapeutics is a Sell
- The Bollinger Bands (100) for Black Diamond Therapeutics is (4.76 - 6.2), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.